-- Merck, Schering-Plough cut losses on Vytorin study
-- 
-- Mon Jul 21, 2008 5:10pm EDT
-- http://www.reuters.com/article/2008/07/21/us-merck-scheringplough-vytorin-shares-idUSN2143211420080721

 

 NEW YORK  (Reuters) - Shares of Merck & Co briefly turned positive on Monday and those of Schering Plough sharply pared losses after the outcome of a new study of their Vytorin cholesterol fighter was announced. 

 Shares of Merck, a Dow component, were last off 1.5 percent at $37.10 on the New York Stock Exchange, recovering from an earlier slide of more than 5 percent. Shares of Schering-Plough were down 6.2 percent at $20.09 on the NYSE, after having dropped by as much as 15 percent before the outcome of the study was published.  (Reporting by  Ellis Mnyandu ; Editing by Leslie Adler)